Showing results (581-590 of 993) with videos related to

Sort By:
Pageof 100
The Journal of Urology|March 1, 1989
Epidermal growth factor receptor in human bladder cancer: a comparison of immunohistochemistry and ligand bindingD E Neal, K Smith, J A Fennelly, et al.
British Journal of Cancer|July 17, 2003
Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxaneH Anderson, J T Yap, P Wells, et al.
British Journal of Cancer|February 1, 1993
Hormonal treatment of pancreatic carcinoma: a phase II study of LHRH agonist goserelin plus hydrocortisoneP A Philip, J Carmichael, K Tonkin, et al.
Cancer Research|July 1, 1996
Microvessel count predicts survival in uveal melanomaA J Foss, R A Alexander, L W Jefferies, et al.
Histopathology|January 1, 1993
Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphomaF Pezzella, H Morrison, M Jones, et al.
British Journal of Cancer|August 26, 2004
The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancersJ Chakrabarti, H Turley, L Campo, et al.
British Journal of Cancer|December 1, 1991
Phase II trial of didox in advanced breast cancer. Cancer Research Campaign Phase I/II Clinical Trials CommitteeR D Rubens, S B Kaye, M Soukop, et al.
Cancer Research|November 15, 1989
Possible role of inhibition of glutathione S-transferase in the partial reversal of chlorambucil resistance by indomethacin in a Chinese hamster ovary cell lineA Hall, C N Robson, I D Hickson, et al.
The British Journal of Ophthalmology|March 1, 1997
Reassessment of the PAS patterns in uveal melanomaA J Foss, R A Alexander, J L Hungerford, et al.
British Journal of Cancer|April 26, 2000
Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviourH E Turner, Z Nagy, K C Gatter, et al.
Pageof 100